グローバル酵母感染症の治療市場規模、主要企業シェア、ランキング分析レポート【2026年版】

Yeast Infection Treatment - Global Top Players Market Share and Ranking 2026
  • レポートID:
    224172
  • 発表時期:
    2026-03-03
  • レポート形式:
    PDF
  • 産業カテゴリー:
    薬品及びサプリメント
  • レポート言語:
    英語、日本語
  • ページ数:
    105
  • 発行会社(調査会社):
    YHResearch
title

言語とエディションの価格

  • 英語版
  • 日本語版
  • 英語と日本語版

個人版詳細

マルチユーザー版詳細

企業版詳細

  • 英語版
  • 日本語版
  • 英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=162.40円

※米ドル表示価格+10%消費税。

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

title

レポートの概要

本報告書は、世界の酵母感染症の治療市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から酵母感染症の治療市場を分析し、需要構造と成長特性を明確化します。
酵母感染症の治療市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、酵母感染症の治療に関する的確な意思決定を行うための実践的なインサイトを提供します。
 主要酵母感染症の治療市場の統計
2025年世界市場規模:百万米ドル
2026年世界市場規模:百万米ドル
2032年予測市場規模:百万米ドル
2026–2032年予測期間CAGR:
本レポートは酵母感染症の治療市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。 
【市場セグメンテーション】
主要企業・競争環境
酵母感染症の治療市場の主要企業には以下が含まれます:
Bayer
Merck & Co., Inc.
Pfizer Inc.
Abbott Laboratories
Allergan
Astra Zeneca
Sanofi
Corden Pharma
Astellas Pharma Inc.
Novartis
Brundavan Laboratories Private Limited
Synmedic Laboratories

製品別
Powders
Creams/Ointments
Tablets/Capsules
Others

アプリケーション別
Retail Pharmacies/Drug Stores
Hospital Pharmacies
Specialty Stores
Online Sales
Others

レポート対象地域
北米:アメリカ、カナダ、その他
アジア太平洋:中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ:メキシコ、ブラジル、その他
中東・アフリカ:トルコ、サウジアラビア、UAE、その他

レポート構成(章別概要)
第1章|市場概要と成長展望
酵母感染症の治療市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章|主要企業の競争分析
酵母感染症の治療市場における主要プレイヤー(トップ5社・トップ10社)を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章|製品カテゴリ別市場動向
製品タイプ別に酵母感染症の治療市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章|用途別市場動向
用途別に酵母感染症の治療市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章|地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、酵母感染症の治療市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章|国別市場動向
主要国・地域ごとに、酵母感染症の治療市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章|主要企業プロファイル
酵母感染症の治療市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章|バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章|調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章|付録(調査手法・データソース)
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します

本レポートの要点と洞察
 酵母感染症の治療市場の全体像と成長見通し
酵母感染症の治療市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が酵母感染症の治療市場に与える影響を分析いたします
 市場環境の構成要素とマクロトレンド
酵母感染症の治療産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
 競争構造と主要企業の動向分析
酵母感染症の治療市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
 競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から酵母感染症の治療市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
 成長要因・課題・リスクの分析
酵母感染症の治療市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
 将来トレンドと市場展望
酵母感染症の治療市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
title

Description

According to YH Research, the global market for Yeast Infection Treatment should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.

By country, Japan accounted for percent of the global market last year and Japan’s market share increased from percent to percent. Japan Yeast Infection Treatment market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032. The United States Yeast Infection Treatment market should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of % for the period of 2026-2032.
By segment, Retail Pharmacies/Drug Stores grew percent to account for percent of the total market sales, and Hospital Pharmacies grew percent.

This report studies and analyses global Yeast Infection Treatment status and future trends, to help determine the Yeast Infection Treatment market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Yeast Infection Treatment, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Yeast Infection Treatment market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Yeast Infection Treatment by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Yeast Infection Treatment by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Yeast Infection Treatment key consuming regions, consumption value and demand structure
(5) Yeast Infection Treatment industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bayer
Merck & Co., Inc.
Pfizer Inc.
Abbott Laboratories
Allergan
Astra Zeneca
Sanofi
Corden Pharma
Astellas Pharma Inc.
Novartis
Brundavan Laboratories Private Limited
Synmedic Laboratories

Market segment by Type, covers
Powders
Creams/Ointments
Tablets/Capsules
Others

Market segment by Application, can be divided into
Retail Pharmacies/Drug Stores
Hospital Pharmacies
Specialty Stores
Online Sales
Others

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Yeast Infection Treatment product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Yeast Infection Treatment market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Yeast Infection Treatment market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Yeast Infection Treatment industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions
title

Table of Contents

1 Market Overview
1.1 Yeast Infection Treatment Definition
1.2 Global Yeast Infection Treatment Market Size and Forecast
1.3 Japan Yeast Infection Treatment Market Size and Forecast
1.4 Share of Japan Yeast Infection Treatment Market with Respect to the Global Market
1.5 Yeast Infection Treatment Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Yeast Infection Treatment Market Dynamics
1.6.1 Yeast Infection Treatment Market Drivers
1.6.2 Yeast Infection Treatment Market Restraints
1.6.3 Yeast Infection Treatment Industry Trends
1.6.4 Yeast Infection Treatment Industry Policy
2 Global Leading Players and Market Share
2.1 By Revenue of Yeast Infection Treatment, Global Market Share by Company, 2021-2026
2.2 Global Yeast Infection Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Yeast Infection Treatment Concentration Ratio
2.4 Global Yeast Infection Treatment Mergers & Acquisitions, Expansion Plans
2.5 Global Yeast Infection Treatment Major Companies Product Type
2.6 Head Office and Area Served of Key Players
3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Yeast Infection Treatment, Japan Market Share by Company, 2021-2026
3.2 Japan Yeast Infection Treatment Yeast Infection Treatment Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Industry Chain Analysis
4.1 Yeast Infection Treatment Industry Chain
4.2 Yeast Infection Treatment Upstream Analysis
4.2.1 Yeast Infection Treatment Core Raw Materials
4.2.2 Main Manufacturers of Yeast Infection Treatment Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Yeast Infection Treatment Production Mode
4.6 Yeast Infection Treatment Procurement Model
4.7 Yeast Infection Treatment Industry Sales Model and Sales Channels
4.7.1 Yeast Infection Treatment Sales Model
4.7.2 Yeast Infection Treatment Typical Distributors
5 Sights by Type
5.1 Yeast Infection Treatment Classification by Type
5.1.1 Powders
5.1.2 Creams/Ointments
5.1.3 Tablets/Capsules
5.1.4 Others
5.2 by Type, Global Yeast Infection Treatment Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Yeast Infection Treatment Consumption Value, 2021-2032
6 Sights by Application
6.1 Yeast Infection Treatment Segment by Application
6.1.1 Retail Pharmacies/Drug Stores
6.1.2 Hospital Pharmacies
6.1.3 Specialty Stores
6.1.4 Online Sales
6.1.5 Others
6.2 by Application, Global Yeast Infection Treatment Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Yeast Infection Treatment Consumption Value, 2021-2032
7 Sales Sights by Region
7.1 By Region, Global Yeast Infection Treatment Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Yeast Infection Treatment Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Yeast Infection Treatment Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Yeast Infection Treatment Market Size Market Share
7.4 Europe
7.4.1 Europe Yeast Infection Treatment Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Yeast Infection Treatment Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Yeast Infection Treatment Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Yeast Infection Treatment Market Size Market Share
7.6 South America
7.6.1 South AmericaYeast Infection Treatment Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Yeast Infection Treatment Market Size Market Share
7.7 Middle East & Africa
8 Sales Sights by Country Level
8.1 By Country, Global Yeast Infection Treatment Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Yeast Infection Treatment Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Yeast Infection Treatment Market Size, 2021-2032
8.3.2 by Type, United States Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Yeast Infection Treatment Market Size, 2021-2032
8.4.2 by Type, Europe Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Yeast Infection Treatment Market Size, 2021-2032
8.5.2 by Type, China Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Yeast Infection Treatment Market Size, 2021-2032
8.6.2 by Type, Japan Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Yeast Infection Treatment Market Size, 2021-2032
8.7.2 by Type, South Korea Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Yeast Infection Treatment Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Yeast Infection Treatment Market Size, 2021-2032
8.9.2 by Type, India Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Yeast Infection Treatment Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
9 Company Profile
9.1 Bayer
9.1.1 Bayer Company Information, Head Office, Market Area, and Industry Position
9.1.2 Bayer Company Profile and Main Business
9.1.3 Bayer Yeast Infection Treatment Models, Specifications, and Application
9.1.4 Bayer Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.1.5 Bayer Recent Developments
9.2 Merck & Co., Inc.
9.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
9.2.2 Merck & Co., Inc. Company Profile and Main Business
9.2.3 Merck & Co., Inc. Yeast Infection Treatment Models, Specifications, and Application
9.2.4 Merck & Co., Inc. Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.2.5 Merck & Co., Inc. Recent Developments
9.3 Pfizer Inc.
9.3.1 Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
9.3.2 Pfizer Inc. Company Profile and Main Business
9.3.3 Pfizer Inc. Yeast Infection Treatment Models, Specifications, and Application
9.3.4 Pfizer Inc. Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.3.5 Pfizer Inc. Recent Developments
9.4 Abbott Laboratories
9.4.1 Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
9.4.2 Abbott Laboratories Company Profile and Main Business
9.4.3 Abbott Laboratories Yeast Infection Treatment Models, Specifications, and Application
9.4.4 Abbott Laboratories Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.4.5 Abbott Laboratories Recent Developments
9.5 Allergan
9.5.1 Allergan Company Information, Head Office, Market Area, and Industry Position
9.5.2 Allergan Company Profile and Main Business
9.5.3 Allergan Yeast Infection Treatment Models, Specifications, and Application
9.5.4 Allergan Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.5.5 Allergan Recent Developments
9.6 Astra Zeneca
9.6.1 Astra Zeneca Company Information, Head Office, Market Area, and Industry Position
9.6.2 Astra Zeneca Company Profile and Main Business
9.6.3 Astra Zeneca Yeast Infection Treatment Models, Specifications, and Application
9.6.4 Astra Zeneca Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.6.5 Astra Zeneca Recent Developments
9.7 Sanofi
9.7.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
9.7.2 Sanofi Company Profile and Main Business
9.7.3 Sanofi Yeast Infection Treatment Models, Specifications, and Application
9.7.4 Sanofi Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.7.5 Sanofi Recent Developments
9.8 Corden Pharma
9.8.1 Corden Pharma Company Information, Head Office, Market Area, and Industry Position
9.8.2 Corden Pharma Company Profile and Main Business
9.8.3 Corden Pharma Yeast Infection Treatment Models, Specifications, and Application
9.8.4 Corden Pharma Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.8.5 Corden Pharma Recent Developments
9.9 Astellas Pharma Inc.
9.9.1 Astellas Pharma Inc. Company Information, Head Office, Market Area, and Industry Position
9.9.2 Astellas Pharma Inc. Company Profile and Main Business
9.9.3 Astellas Pharma Inc. Yeast Infection Treatment Models, Specifications, and Application
9.9.4 Astellas Pharma Inc. Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.9.5 Astellas Pharma Inc. Recent Developments
9.10 Novartis
9.10.1 Novartis Company Information, Head Office, Market Area, and Industry Position
9.10.2 Novartis Company Profile and Main Business
9.10.3 Novartis Yeast Infection Treatment Models, Specifications, and Application
9.10.4 Novartis Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.10.5 Novartis Recent Developments
9.11 Brundavan Laboratories Private Limited
9.11.1 Brundavan Laboratories Private Limited Company Information, Head Office, Market Area, and Industry Position
9.11.2 Brundavan Laboratories Private Limited Company Profile and Main Business
9.11.3 Brundavan Laboratories Private Limited Yeast Infection Treatment Models, Specifications, and Application
9.11.4 Brundavan Laboratories Private Limited Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.11.5 Brundavan Laboratories Private Limited Recent Developments
9.12 Synmedic Laboratories
9.12.1 Synmedic Laboratories Company Information, Head Office, Market Area, and Industry Position
9.12.2 Synmedic Laboratories Company Profile and Main Business
9.12.3 Synmedic Laboratories Yeast Infection Treatment Models, Specifications, and Application
9.12.4 Synmedic Laboratories Yeast Infection Treatment Revenue and Gross Margin, 2021-2026
9.12.5 Synmedic Laboratories Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
title

Table of Figures

List of Tables
 Table 1. Yeast Infection Treatment Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million
 Table 2. Yeast Infection Treatment Market Restraints
 Table 3. Yeast Infection Treatment Market Trends
 Table 4. Yeast Infection Treatment Industry Policy
 Table 5. Global Yeast Infection Treatment Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 6. Global Yeast Infection Treatment Revenue Share by Company, 2021-2026, Ranked by Data of 2025
 Table 7. Global Yeast Infection Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)
 Table 8. Global Yeast Infection Treatment Mergers & Acquisitions, Expansion Plans
 Table 9. Global Yeast Infection Treatment Major Companies Product Type
 Table 10. Head Office and Area Served of Key Players
 Table 11. Japan Yeast Infection Treatment Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025
 Table 12. Japan Yeast Infection Treatment Revenue Market Share by Company, 2021-2026
 Table 13. Global Key Players of Yeast Infection Treatment Upstream (Raw Materials)
 Table 14. Global Yeast Infection Treatment Typical Customers
 Table 15. Yeast Infection Treatment Typical Distributors
 Table 16. by Type, Global Yeast Infection Treatment Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 17. by Application, Global Yeast Infection Treatment Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 18. By Region, Global Yeast Infection Treatment Consumption Value, 2021 VS 2025 VS 2032, US$ Million
 Table 19. By Region, Global Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Table 20. By Country, Global Yeast Infection Treatment Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million
 Table 21. By Country, Global Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Table 22. By Country, Global Yeast Infection Treatment Consumption Value Market Share, 2021-2032
 Table 23. Bayer Company Information, Head Office, Market Area, and Industry Position
 Table 24. Bayer Company Profile and Main Business
 Table 25. Bayer Yeast Infection Treatment Models, Specifications, and Application
 Table 26. Bayer Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 27. Bayer Recent Developments
 Table 28. Merck & Co., Inc. Company Information, Head Office, Market Area, and Industry Position
 Table 29. Merck & Co., Inc. Company Profile and Main Business
 Table 30. Merck & Co., Inc. Yeast Infection Treatment Models, Specifications, and Application
 Table 31. Merck & Co., Inc. Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 32. Merck & Co., Inc. Recent Developments
 Table 33. Pfizer Inc. Company Information, Head Office, Market Area, and Industry Position
 Table 34. Pfizer Inc. Company Profile and Main Business
 Table 35. Pfizer Inc. Yeast Infection Treatment Models, Specifications, and Application
 Table 36. Pfizer Inc. Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 37. Pfizer Inc. Recent Developments
 Table 38. Abbott Laboratories Company Information, Head Office, Market Area, and Industry Position
 Table 39. Abbott Laboratories Company Profile and Main Business
 Table 40. Abbott Laboratories Yeast Infection Treatment Models, Specifications, and Application
 Table 41. Abbott Laboratories Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 42. Abbott Laboratories Recent Developments
 Table 43. Allergan Company Information, Head Office, Market Area, and Industry Position
 Table 44. Allergan Company Profile and Main Business
 Table 45. Allergan Yeast Infection Treatment Models, Specifications, and Application
 Table 46. Allergan Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 47. Allergan Recent Developments
 Table 48. Astra Zeneca Company Information, Head Office, Market Area, and Industry Position
 Table 49. Astra Zeneca Company Profile and Main Business
 Table 50. Astra Zeneca Yeast Infection Treatment Models, Specifications, and Application
 Table 51. Astra Zeneca Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 52. Astra Zeneca Recent Developments
 Table 53. Sanofi Company Information, Head Office, Market Area, and Industry Position
 Table 54. Sanofi Company Profile and Main Business
 Table 55. Sanofi Yeast Infection Treatment Models, Specifications, and Application
 Table 56. Sanofi Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 57. Sanofi Recent Developments
 Table 58. Corden Pharma Company Information, Head Office, Market Area, and Industry Position
 Table 59. Corden Pharma Company Profile and Main Business
 Table 60. Corden Pharma Yeast Infection Treatment Models, Specifications, and Application
 Table 61. Corden Pharma Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 62. Corden Pharma Recent Developments
 Table 63. Astellas Pharma Inc. Company Information, Head Office, Market Area, and Industry Position
 Table 64. Astellas Pharma Inc. Company Profile and Main Business
 Table 65. Astellas Pharma Inc. Yeast Infection Treatment Models, Specifications, and Application
 Table 66. Astellas Pharma Inc. Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 67. Astellas Pharma Inc. Recent Developments
 Table 68. Novartis Company Information, Head Office, Market Area, and Industry Position
 Table 69. Novartis Company Profile and Main Business
 Table 70. Novartis Yeast Infection Treatment Models, Specifications, and Application
 Table 71. Novartis Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 72. Novartis Recent Developments
 Table 73. Brundavan Laboratories Private Limited Company Information, Head Office, Market Area, and Industry Position
 Table 74. Brundavan Laboratories Private Limited Company Profile and Main Business
 Table 75. Brundavan Laboratories Private Limited Yeast Infection Treatment Models, Specifications, and Application
 Table 76. Brundavan Laboratories Private Limited Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 77. Brundavan Laboratories Private Limited Recent Developments
 Table 78. Synmedic Laboratories Company Information, Head Office, Market Area, and Industry Position
 Table 79. Synmedic Laboratories Company Profile and Main Business
 Table 80. Synmedic Laboratories Yeast Infection Treatment Models, Specifications, and Application
 Table 81. Synmedic Laboratories Yeast Infection Treatment Revenue and Gross Margin, US$ Million, 2021-2026
 Table 82. Synmedic Laboratories Recent Developments


List of Figures
 Figure 1. Yeast Infection Treatment Picture
 Figure 2. Global Yeast Infection Treatment Consumption Value, (US$ million) & (2021-2032)
 Figure 3. Japan Yeast Infection Treatment Consumption Value, (US$ million) & (2021-2032)
 Figure 4. By Consumption Value, Japan Yeast Infection Treatment Market Share of Global, 2021-2032
 Figure 5. Global Yeast Infection Treatment Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025
 Figure 6. Japan Yeast Infection Treatment Key Participants, Market Share, 2025
 Figure 7. Yeast Infection Treatment Industry Chain
 Figure 8. Yeast Infection Treatment Procurement Model
 Figure 9. Yeast Infection Treatment Sales Model
 Figure 10. Yeast Infection Treatment Sales Channels, Direct Sales, and Distribution
 Figure 11. Powders
 Figure 12. Creams/Ointments
 Figure 13. Tablets/Capsules
 Figure 14. Others
 Figure 15. by Type, Global Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 16. by Type, Global Yeast Infection Treatment Consumption Value Market Share, 2021-2032
 Figure 17. Retail Pharmacies/Drug Stores
 Figure 18. Hospital Pharmacies
 Figure 19. Specialty Stores
 Figure 20. Online Sales
 Figure 21. Others
 Figure 22. by Application, Global Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 23. by Application, Global Yeast Infection Treatment Revenue Market Share, 2021-2032
 Figure 24. By Region, Global Yeast Infection Treatment Consumption Value Market Share, 2021-2032
 Figure 25. North America Yeast Infection Treatment Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 26. By Country, North America Yeast Infection Treatment Consumption Value Market Share, 2025
 Figure 27. Europe Yeast Infection Treatment Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 28. By Country, Europe Yeast Infection Treatment Consumption Value Market Share, 2025
 Figure 29. Asia Pacific Yeast Infection Treatment Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 30. By Country/Region, Asia Pacific Yeast Infection Treatment Consumption Value Market Share, 2025
 Figure 31. South America Yeast Infection Treatment Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 32. By Country, South America Yeast Infection Treatment Consumption Value Market Share, 2025
 Figure 33. Middle East & Africa Yeast Infection Treatment Consumption Value & Forecasts, 2021-2032, US$ Million
 Figure 34. United States Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 35. by Type, United States Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 36. by Application, United States Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 37. Europe Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 38. by Type, Europe Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 39. by Application, Europe Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 40. China Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 41. by Type, China Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 42. by Application, China Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 43. Japan Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 44. by Type, Japan Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 45. by Application, Japan Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 46. South Korea Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 47. by Type, South Korea Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 48. by Application, South Korea Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 49. Southeast Asia Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 50. by Type, Southeast Asia Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 51. by Application, Southeast Asia Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 52. India Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 53. by Type, India Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 54. by Application, India Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 55. Middle East & Africa Yeast Infection Treatment Consumption Value, 2021-2032, US$ Million
 Figure 56. by Type, Middle East & Africa Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 57. by Application, Middle East & Africa Yeast Infection Treatment Consumption Value Market Share, 2025 VS 2032
 Figure 58. Research Methodology
 Figure 59. Breakdown of Primary Interviews
 Figure 60. Bottom-up Approaches
 Figure 61. Top-down Approaches

お見積>

サンプルお申込み>

今すぐ購入>

PDFダウンロード>